SUMMARY
The problem of Helicobacter pylori infection and associated gastrointestinal tract lesions continues to be a topical issue in the field of gastroenterology. Given the high rates of proximal gastrointestinal tract cancer in our country (in particular, stomach cancer), the study of Helicobacter pylori-associated diseases should be of real interest and is a popular area of national gastroenterology and oncology. Thus, as revealed by the authors as a result of the primary analysis, one of the key problems of seeking medical care among young and middle-aged patients was the manifestations of dyspepsia. The obtained results confirm the choice of non-invasive methods as the main diagnostic principles for dyspepsia. The results provide valuable information for the creation of national screening strategies and opportunities for its improvement, treatment issues, as well as prevention among the local population.
Keywords: Helicobacter pylori, endoscopic gastroduodenoscopy, stomach cancer

---

REFERENCES

1. Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz Ch, Gasbarrini A, et al. Management of Helicobacter pylori infection: the Maastricht VI Florence consensus report // Gut 2022;0:1-39. doi:10.1136/gutjnl2022327745.
2. Jonaitis P, Nyssen OP, Saracino IM, Fiorini G, Vaira D, Tepes B, et al. Comparison of the management of Helicobacter pylori infection between the older and younger European populations // Sci Rep. 2023;13(1):17235. DOI: 10.1038/s41598-023-43287-4.
3. Rabeneck L, Wristers K, Souchek J, Ambriz E. Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia // Gastrointest Endosc. 2003 Mar;57(3):295-9. doi: 10.1067/mge.2003.122.
4. Quadri A, Vakil N. Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia // Aliment Pharmacol Ther. 2003 Mar 15;17(6):835-40. doi: 10.1046/j.1365-2036.2003.01497.x.
5. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders // Gut 1999;45(suppl II):II37-42.
6. ASGE Standards of Practice Committee; Shaukat A, Wang A, Acosta RD, Bruining DH, Chandrasekhara V, Chathadi KV, Eloubeidi MA, Fanelli RD, Faulx AL, Fonkalsrud L, Gurudu SR, Kelsey LR, Khashab MA, Kothari S, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Yang J, Cash BD, DeWitt JM. The role of endoscopy in dyspepsia // Gastrointest Endosc. 2015 Aug;82(2):227-32. doi: 10.1016/j.gie.2015.04.003.
7. McColl KE, Dickson A, El-Nujumi A, El-Omar E, Kelman A. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease // Am J Gastroenterol. 2000 Jan;95(1):101-5. doi: 10.1111/j.1572-0241.2000.01706.x.
8. Mao LQ, Wang SS, Zhou YL, Chen L, Yu LM, Li M, Lv B. Clinically significant endoscopic findings in patients of dyspepsia with no warning symptoms: A cross-sectional study // World J Clin Cases. 2021 May 26;9(15):3597-3606. doi: 10.12998/wjcc. v9.i15.3597.
9. Nasseri-Moghaddam S, Mousavian AH, Kasaeian A. et. al. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Updated Systematic Review and Meta-analysis // Clin Gastroent. Hepatol. 2022;20:S1542-3565(22)00594-8. doi: 10.1016/j.cgh.2022. 05.041.
10. Huang H, Rong Y, Wang M, Guo Z, Yu Y, Long Z, Chen X, Wang H, Ding J, Yan L, Peng J. Analysis of gastroscopy results among healthy people undergoing a medical checkup: a retrospective study // BMC Gastroenterol. 2020 Dec 9;20(1):412. doi: 10.1186/s12876-020-01557-9.
11. Katz, Philip O., Dunbar, Kerry B., Schnoll-Sussman, Felice H., Greer, Katarina B., Yadlapati, Rena, Spechler, Stuart Jon. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease // The American Journal of Gastroenterology 117(1):p 27-56, January 2022. | DOI: 10.14309/ajg.0000000000001538.
12. Agayeva S., Katzka D., Afandiyeva N., Bor S., Babayeva G.H., Hidayatov А.А., Мammadzada G. The Prevalence of Gastroesophageal Reflux Disease in Azerbaijan: A Population-Based Cross-sectional Study // Turk J Gastroenterol 2023; 9: -1-10 DOI: 10.5152/tjg.2023.211042
13. Sugimoto M, Uotani T, Ichikawa H, Andoh A, Furuta T. Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan // Digestion. 2016; 93:24-31.
14. García-Morales N., Pérez-Aísa Á., Fiorini G., Tepes B., et al. Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management // J. Clin. Med. 2023, 12(13), 4363; https://doi.org/10.3390/jcm12134363
15. Burucoa, C., Axon, A. Epidemiology of Helicobacter pylori infection // Helicobacter 2017, 22, e12403.
16. Wroblewski, L.E.; Peek, R.M.; Wilson, K.T. Helicobacter pylori and gastric cancer: Factors that modulate disease risk // Clin. Microbiol. Rev. 2010, 23, 713-739.
17. Polk, D.B.; Peek, R.M. Helicobacter pylori: Gastric cancer and beyond // Nat. Rev. Cancer 2010, 10, 403-414.
18. Conteduca, V.; Sansonno, D.; Lauletta, G.; Russi, S.; Ingravallo, G.; Dammacco, F.H. pylori infection and gastric cancer: State of the art (review) // Int. J. Oncol. 2013, 42, 5-18.
19. Bourke, B.; Ceponis, P.; Chiba, N.; Czinn, S.; Ferraro, R.; Fischbach, L.; Gold, B.; Hyunh, H.; Jacobson, K.; Jones, N.L.; et al. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents—An evidence-based evaluation / Can. J. Gastroenterol. 2005, 19, 399-408.
20. Rothenbacher, D., Brenner, H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: Recent developments and future implications // Microbes. Infect. 2003, 5, 693-703.
21. Jafri, W.; Yakoob, J.; Abid, S.; Siddiqui, S.; Awan, S.; Nizami, S.Q. Helicobacter pylori infection in children: Population-based age-specific prevalence and risk factors in a developing country // Acta Paediatr. 2010, 99, 279-282.
22. Ghoshal, U.C.; Chaturvedi, R.; Correa, P. The enigma of Helicobacter pylori infection and gastric cancer // Indian J. Gastroenterol. 2010, 29, 95-100.
23. Leung WK, Wong IOL, Cheung KS, Yeung KF, et al. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals // Gastroenterology. 2018 Jul;155(1):67-75. doi: 10.1053/j.gastro.2018.03.028.
24. Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey:a nationally-representative, cross-sectional, screening with the ¹³C-Urea breath test // BMC Public Health.2013;13:1215.
25. Bayındır Bilman F, Özdemir M, Baysal B, Güzel Kurtoğlu M. Prevalence of H. pylori in gastric biopsy specimen in the southeastern region of Turkey // J Infect Dev Ctries. 2016;10:1177-82.
26. Kowada A. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter Pylori Eradication // Dig Dis Sci. 2021; 66(12):4220-4226. doi: 10.1007/s10620-020-06813-2.
27. Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice // World J Gastroenterol. 2019 Jul 21;25(27):3546-3562. doi: 10.3748/wjg.v25.i27.3546.
28. Stanghellini V, Chan FK, Hasler W.L. et. al. Gastroduodenal Disorders // Gastroenterology. 2016 May; 150(6):1380-92. doi:10.1053/ j.gastro.2016.02.011.
29. Costa, José. "Cancer". Encyclopedia Britannica, 2023, https://www.britannica.com/ science/cancer-disease. Accessed 14 June 2023.
30. Keighley MR. Gastrointestinal cancers in Europe // Aliment Pharmacol Ther. 2003 Nov;18 (Suppl 3):7-30. doi:10.1046/j.0953-0673.2003.01722.x.
31. Xie SH, Lagergren J. Time trends in the incidence of oesophageal cancer in Asia: variations across populations and histological types // Cancer Epidemiol. 2016 Oct;44:71-6. doi:10.1016/j.canep.2016.08.002.
32. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma // N Engl J Med. 1999 Mar 18;340 (11):825-31. doi:10.1056/NEJM199903183401101.
33. Chen YH, Yu HC, Lin KH, Lin HS, Hsu PI. Prevalence and risk factors for Barrett’s esophagus in Taiwan // World J Gastroenterol. 2019 Jul 7;25(25):3231-41. doi:10.3748/wjg.v25.i25.3231.
34. Kato M, Asaka M, Shimizu Y, Nobuta A, Takeda H, Sugiyama T. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer // Aliment Pharmacol Ther. 2004 Jul;20 (Suppl 1):85-9. doi:10.1111/j.1365-2036. 2004. 01987.x.
35. McColl KE. Cancer of the gastric cardia // Best Pract Res Clin Gastroenterol. 2006;20(4):687-96. doi:10.1016/j.bpg.2006.03.005.
36. Kamada T, Kurose H, Yamanaka Y, Manabe N, Kusunoki H, Shiotani A.  Relationship between gastroesophageal junction adenocarcinoma and Helicobacter pylori infection in Japan // Digestion. 2012;85(4):256-60. doi:10.1159/000336352.
37. Take S, Mizuno M, Ishiki K, Hamada F, Yoshida T, Yokota K. Low incidence of esophageal adenocarcinoma after eradication of Helicobacter pylori in Japan // Clin Gastroenterol Hepatol. 2018 Dec;16(12):1995-6. doi:10.1016/j.cgh.2018.03.030.
38. Azərbaycan Respublikasının Dövlət Statistika Komitəsi. www.azstat.org
39. International Agency for Research on Cancer. https://gco.iarc.fr/today/data/factsheets/ populations/31-azerbaijan-fact-sheets.pdf
40. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660.